Literature DB >> 11923556

Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival.

A Baldi1, A M Groeger, V Esposito, R Cassandro, G Tonini, T Battista, M P Di Marino, B Vincenzi, M Santini, A Angelini, R Rossiello, F Baldi, M G Paggi.   

Abstract

BACKGROUND: Mesothelioma is the most commonly occurring primary pleural neoplasm. Several studies have documented an increase in the incidence of this malignancy during the last decades. Although the association between asbestos exposure and development of mesothelioma is generally accepted, the exact mechanism of carcinogenesis is unknown. Recently, Simian virus 40 large T antigen (SV40 Tag) expression has been detected in pleural mesothelioma. The ability of SV40 oncoproteins to inactivate p53 and retinoblastoma tumour suppressor proteins has been proposed as an important step in the pathogenesis of human mesothelioma.
METHODS: To obtain a better understanding of the molecular mechanisms of the pathogenesis of mesothelioma, the expression of the cell cycle inhibitor p21(WAF1/CIP1) (p21), a downstream target of p53, was evaluated immunohistochemically in a group of 29 mesothelioma specimens already characterised for the presence of SV40 Tag sequences.
RESULTS: Statistical analysis did not reveal any correlation between p21 expression and histopathological type of mesothelioma using the kappa(2) test (p=0.577). A significant positive relationship was found between p21 expression level and the patients' overall survival according to the Kaplan-Meier survival curves and using a log rank test (median difference in survival 7 months, 95% CI 4.8 to 9.9; p<0.001).
CONCLUSIONS: Determination of p21 expression bears a prognostic significance in patients affected with mesothelioma, further underlining the role of SV40 in the pathogenesis of malignant pleural mesothelioma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923556      PMCID: PMC1746306          DOI: 10.1136/thorax.57.4.353

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  27 in total

1.  Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells.

Authors:  C T Yang; L You; C C Yeh; J W Chang; F Zhang; F McCormick; D M Jablons
Journal:  J Natl Cancer Inst       Date:  2000-04-19       Impact factor: 13.506

2.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

3.  Simian virus 40 and human pleural mesothelioma.

Authors:  C Mulatero; T Surentheran; J Breuer; R M Rudd
Journal:  Thorax       Date:  1999-01       Impact factor: 9.139

4.  Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity.

Authors:  D S Franklin; V L Godfrey; D A O'Brien; C Deng; Y Xiong
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

5.  Simian virus 40-like DNA sequences in human pleural mesothelioma.

Authors:  M Carbone; H I Pass; P Rizzo; M Marinetti; M Di Muzio; D J Mew; A S Levine; A Procopio
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

6.  Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas.

Authors:  J Q Cheng; S C Jhanwar; Y Y Lu; J R Testa
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

7.  Malignant mesothelioma. The University of Minnesota experience.

Authors:  N J Vogelzang; S M Schultz; A M Iannucci; B J Kennedy
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

Review 8.  Asbestos exposure--quantitative assessment of risk.

Authors:  J M Hughes; H Weill
Journal:  Am Rev Respir Dis       Date:  1986-01

9.  SV40 induces mesotheliomas in hamsters.

Authors:  C Cicala; F Pompetti; M Carbone
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

10.  The European mesothelioma epidemic.

Authors:  J Peto; A Decarli; C La Vecchia; F Levi; E Negri
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

View more
  5 in total

1.  Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma.

Authors:  Wen-Bin Ou; Christopher Hubert; Joseph M Corson; Raphael Bueno; Daniel L Flynn; David J Sugarbaker; Jonathan A Fletcher
Journal:  Neoplasia       Date:  2011-01       Impact factor: 5.715

2.  Synergistic effect of gefitinib and rofecoxib in mesothelioma cells.

Authors:  Daniela Stoppoloni; Claudia Canino; Irene Cardillo; Alessandra Verdina; Alfonso Baldi; Ada Sacchi; Rossella Galati
Journal:  Mol Cancer       Date:  2010-02-02       Impact factor: 27.401

3.  Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma.

Authors:  A Baldi; D Santini; F Vasaturo; M Santini; G Vicidomini; M Pia Di Marino; V Esposito; A M Groeger; G Liuzzi; B Vincenzi; G Tonini; M Piccoli; F Baldi; S Scarpa
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

4.  Expression of cancer-associated molecules in malignant mesothelioma.

Authors:  Ben Davidson
Journal:  Biomark Insights       Date:  2007-05-30

5.  Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability.

Authors:  Alessandra Verdina; Irene Cardillo; Angela Nebbioso; Rossella Galati; Simona Menegozzo; Lucia Altucci; Ada Sacchi; Alfonso Baldi
Journal:  J Transl Med       Date:  2008-05-22       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.